Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.31 -0.7%	$12.00 ➝ $13.00	Neutral
AAPL Apple	Target Set by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Amit Daryanani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$255.46 -0.5%	$260.00 ➝ $290.00	Outperform
AC Air Canada	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.78 -1.1%	C$25.00 ➝ C$24.00	Buy
AC Air Canada	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.78 -1.1%	C$24.00 ➝ C$22.00	Outperform
AC Air Canada	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$17.78 -1.1%	C$25.00 ➝ C$22.00
ACN Accenture	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tien-Tsin Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$302.00 ➝ $290.00	Overweight
ACN Accenture	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$305.00 ➝ $285.00	Buy
ACN Accenture	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Phani Kanumuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$240.00 ➝ $215.00
ACN Accenture	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nate Svensson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$260.00 ➝ $235.00	Hold
ACN Accenture	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$313.00 ➝ $295.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ACN Accenture	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$372.00 ➝ $285.00	Outperform
ACN Accenture	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$350.00 ➝ $330.00	Outperform
ACN Accenture	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schneider Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$370.00 ➝ $330.00	Buy
ACN Accenture	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$239.43 +3.0%	$325.00 ➝ $270.00	Market Perform
ACN Accenture	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$239.43 +3.0%		Buy
ALGT Allegiant Travel	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.58 +2.2%	$52.00 ➝ $65.00	Neutral
ALKS Alkermes	Upgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leonid Timashev Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.89 +2.8%	$42.00 ➝ $44.00	Sector Perform ➝ Outperform
ALL Allstate	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$212.76 +1.4%	$230.00	Buy
ALLR Allarity Therapeutics	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.58 +2.6%	$9.00 ➝ $9.25	Buy
AMGN Amgen	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$272.98 +0.7%	$261.00 ➝ $272.00	Underperform
APLS Apellis Pharmaceuticals	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.37 +0.7%	$26.00 ➝ $18.00	Neutral ➝ Sell
APP AppLovin	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$669.86 +4.7%	$500.00 ➝ $740.00	Overweight
APP AppLovin	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Hodulik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$669.86 +4.7%	$540.00 ➝ $810.00	Buy
ATO Atmos Energy	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$168.49 +1.2%	$164.00 ➝ $170.00	Neutral
ATOM Atome	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 61.97 0.0%	GBX 130 ➝ GBX 140	Speculative Buy
ATX ATEX Resources	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.46	C$3.50 ➝ C$4.00
ATZ Aritzia	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$86.42 +0.8%	C$82.00 ➝ C$96.00	Buy
BAB Babcock International Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,273 +3.2%	GBX 1,360 ➝ GBX 1,440	Buy
BAK Braskem	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tasso Vasconcellos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.62 -14.4%	$5.10 ➝ $3.80	Buy ➝ Neutral
BB BlackBerry	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.96 +6.6%	$4.60	Hold
BB BlackBerry	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Junk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.96 +6.6%	$5.00 ➝ $5.50	Neutral
BB BlackBerry	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Treiber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.96 +6.6%	$4.50
BBD.B Bombardier, Inc. Class B	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$191.42 -1.9%	C$179.00 ➝ C$216.00	Outperform
BBU Brookfield Business Partners	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Hope Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.20 +1.4%	$36.00 ➝ $39.00	Sector Outperform
BBU Brookfield Business Partners	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.20 +1.4%	$33.00 ➝ $39.00	Outperform
BBU Brookfield Business Partners	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Phil Hardie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.20 +1.4%		Outperform
BEP Brookfield Renewable Partners	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.92 +1.5%	$26.00 ➝ $27.00	Neutral
BIP Brookfield Infrastructure Partners	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.08 +4.9%	$34.00 ➝ $35.00	Outperform
BIRK Birkenstock	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.91	$70.00	Outperform
CDTX Cidara Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sara Nik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.50 +6.8%	$74.00 ➝ $110.00	Buy

CGON CG Oncology	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.54 +2.9%	$41.00 ➝ $47.00	Overweight
CIEN Ciena	Upgraded by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$142.13 +3.6%	$127.50 ➝ $175.00	Neutral ➝ Buy
CIFR Cipher Mining	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reginald Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.47 -1.6%	$6.00 ➝ $12.00	Neutral
CLSK Cleanspark	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reginald Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.96 -5.3%	$15.00 ➝ $14.00	Overweight ➝ Neutral
COST Costco Wholesale	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rupesh Parikh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,130.00	Outperform
COST Costco Wholesale	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,042.00 ➝ $1,033.00	Hold
COST Costco Wholesale	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Horvers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,160.00 ➝ $1,050.00	Overweight
COST Costco Wholesale	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,060.00 ➝ $1,025.00	Outperform
COST Costco Wholesale	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$915.95 -2.9%	$1,225.00 ➝ $1,130.00	Overweight
COST Costco Wholesale	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$915.95 -2.9%	$1,333.00 ➝ $1,418.00	Buy
COST Costco Wholesale	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,000.00	Neutral
COST Costco Wholesale	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Kirk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$907.00	Neutral
COST Costco Wholesale	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zhihan Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$915.95 -2.9%	$1,137.00 ➝ $1,140.00	Outperform
CRH CRH	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Feniger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.64 +1.7%	$128.00	Buy
CRNX Crinetics Pharmaceuticals	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Law Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.91 +27.9%	$35.00 ➝ $40.00	Neutral
CRNX Crinetics Pharmaceuticals	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Skorney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.91 +27.9%	$58.00 ➝ $62.00	Outperform
CRNX Crinetics Pharmaceuticals	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Wolleben Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.91 +27.9%	$86.00 ➝ $143.00	Market Outperform
CSU Constellation Software	Downgraded by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3,660.00 -5.9%	C$5,500.00 ➝ C$4,500.00	Outperform ➝ Sector Perform
CSX CSX	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.01 +0.7%	$44.00 ➝ $39.00	Outperform
CTAS Cintas	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leo Carrington Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.24 +1.1%	$172.00 ➝ $176.00	Sell
CWH Camping World	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.51 +1.9%	$21.00 ➝ $22.00	Buy
DAVE Dave	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$218.10 -2.3%	$280.00 ➝ $300.00
DAVE Dave	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.10 -2.3%	$280.00 ➝ $300.00	Market Outperform
DEFT DeFi Technologies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Dede Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.13	$5.50	Buy
DEO Diageo	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Pistacchi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.10 +0.5%	$117.00 ➝ $109.00	Buy
DG Dollar General	Target Lowered by	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$102.06 -0.8%	$130.00 ➝ $115.00
DKS DICK'S Sporting Goods	Initiated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.34 +1.4%	$177.00	Underperform
DKS DICK'S Sporting Goods	Target Set by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.34 +1.4%	$177.00	Underperform
DUK Duke Energy	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.99 +0.5%	$141.00 ➝ $134.00	Buy ➝ Hold
DXCM DexCom	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.10 -1.8%	$112.00 ➝ $90.00	Outperform
DY Dycom Industries	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Luebchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$288.20 +4.9%	$295.00 ➝ $305.00	Overweight
EA Electronic Arts	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$193.35 +14.9%		Neutral
EDR Endeavour Silver	Target Raised by	Ventum Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$10.87 +2.2%	C$9.75 ➝ C$12.15
ENLV Enlivex Therapeutics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03	$13.00	Buy
ENQ EnQuest	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 11.80 -0.5%	GBX 19 ➝ GBX 20	Buy
EOG EOG Resources	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.19 -0.1%	$130.00	Sector Outperform ➝ Sector Perform
FCX Freeport-McMoRan	Target Lowered by	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$35.76 +1.2%	$51.60 ➝ $42.30	Outperform
FHN First Horizon	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Winter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.84 +0.8%	$24.00	Neutral
FNLPF Fresnillo	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.50 +1.4%		Buy
FOXA FOX	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.15 +1.5%	$62.00 ➝ $68.00	Buy
FOXA FOX	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Reif Ehrlich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.15 +1.5%	$65.00 ➝ $70.00	Buy
FRME First Merchants	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Damon Delmonte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.22 -1.9%	$49.00 ➝ $50.00	Outperform
FRME First Merchants	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Tamayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.22 -1.9%		Outperform ➝ Market Perform
FUL H. B. Fuller	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.15 +2.1%	$70.00 ➝ $62.00	Neutral
GH Guardant Health	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Mikson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.03 -0.2%	$65.00 ➝ $75.00	Buy
GLNCY Glencore	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.97 +1.2%		Buy
GLV Glenveagh Properties	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1.88 -1.2%		Buy
GNK Genco Shipping & Trading	Target Set by	SEB Equity Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.32 -0.9%	$23.00
GOVX GeoVax Labs	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.65 +0.8%	$9.00	Buy
GRDN Guardian Pharmacy Services	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Macdonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.08 +2.5%	$28.00 ➝ $30.00	Buy

GUTS Fractyl Health	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.34 +32.7%	$9.00 ➝ $8.00	Buy
HFWA Heritage Financial	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Rulis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.85 +1.0%	$28.00	Buy
HLMA Halma	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,352 -0.6%		Hold
HLMAF Halma	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.69 +2.6%		Overweight
HNNMY Hennes & Mauritz	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.63 +2.2%		Sell
IHG Intercontinental Hotels Group	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Estelle Weingrod Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.05 +4.5%		Neutral ➝ Overweight
IMRX Immuneering	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.08 +1.0%	$13.00 ➝ $20.00	Buy
IMUX Immunic	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.94 +4.5%	$10.00	Buy
IONS Ionis Pharmaceuticals	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salveen Richter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.09 +1.8%	$45.00 ➝ $65.00	Sell ➝ Neutral
IREN IREN	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reginald Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.86 -9.6%	$16.00 ➝ $24.00	Neutral ➝ Underweight
JBL Jabil	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.19 +2.8%	$223.00 ➝ $267.00	Overweight
JBL Jabil	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruplu Bhattacharya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.19 +2.8%	$245.00 ➝ $255.00	Buy
JD JD.com	Upgraded by	Arete Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.50 -1.9%	$41.00	Sell ➝ Buy
JD JD.com	Target Set by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.50 -1.9%	$41.00
JSG Johnson Service Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 148.40 +3.5%	GBX 195	Buy
KD Kyndryl	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.48 -3.7%	$30.00	Equal Weight
KMX CarMax	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%	$74.00 ➝ $47.00	Hold
KMX CarMax	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Montani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%	$80.00 ➝ $52.00	Outperform ➝ In-Line
KMX CarMax	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%	$92.00 ➝ $60.00	Buy
KMX CarMax	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Nagel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%		Outperform ➝ Market Perform
KMX CarMax	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Kennison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%	$90.00 ➝ $60.00	Outperform
KMX CarMax	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.86 -1.6%	$81.00 ➝ $59.00	Outperform
KTOS Kratos Defense & Security Solutions	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Arment Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.28 +2.5%	$70.00 ➝ $87.00	Outperform
KVUE Kenvue	Target Set by	Redburn Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.40 +1.4%	$22.00
KVUE Kenvue	Upgraded by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.40 +1.4%	$22.50 ➝ $22.00	Neutral ➝ Buy
KVYO Klaviyo	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.64 -2.7%	$44.00 ➝ $39.00	Outperform
KVYO Klaviyo	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.64 -2.7%	$45.00 ➝ $43.00	Overweight
KVYO Klaviyo	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.64 -2.7%	$45.00	Buy
KVYO Klaviyo	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.64 -2.7%	$55.00 ➝ $50.00	Overweight
LEVI Levi Strauss & Co.	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Kearney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.06 +1.1%	$24.00 ➝ $26.00	Overweight
LPTH LightPath Technologies	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Buck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.90 +21.5%	$7.00 ➝ $8.00	Buy
LPTH LightPath Technologies	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jaeson Schmidt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.90 +21.5%	$4.00 ➝ $7.50	Buy
LYV Live Nation Entertainment	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Harrigan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.02 +0.0%	$180.00 ➝ $190.00	Buy
MAC Macerich	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.86 +6.5%	$19.00 ➝ $23.00	Neutral ➝ Buy
MARA Marathon Digital	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reginald Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.13 +0.4%	$22.00 ➝ $20.00	Overweight
MCK McKesson	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$760.82 +3.3%	$821.00 ➝ $853.00	Overweight
MDLZ Mondelez International	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.36 +1.3%	$73.00 ➝ $72.00	Outperform
MEOH Methanex	Initiated by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.76 +3.9%	$47.00	Outperform
MGNI Magnite	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.14 -1.2%	$39.00	Buy
MIR Mirion Technologies	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tomohiko Sano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.81 +11.1%	$28.00	Overweight
MPC Marathon Petroleum	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$198.85 +1.2%	$203.00 ➝ $220.00	Buy
MS Morgan Stanley	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$160.13 +0.7%	$130.00 ➝ $155.00	Neutral
MSFT Microsoft	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$511.46 +0.9%	$582.00 ➝ $625.00	Overweight
MTN Vail Resorts	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.88 +0.7%		Cautious
MTN Vail Resorts	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.88 +0.7%	$146.00 ➝ $155.00	Equal Weight
NGLOY Anglo American	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.30 +0.5%		Neutral
NHYDY Norsk Hydro ASA	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.66 -0.4%		Neutral
NXE NexGen Energy	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$12.70 +1.7%	C$16.00 ➝ C$17.00	Buy
OGS ONE Gas	Upgraded by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.12 +3.3%	$77.00 ➝ $86.00	Neutral ➝ Outperform
OKTA Okta	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.16 0.0%	$115.00	Outperform

OKTA Okta	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.16 0.0%	$142.00	Buy
OKTA Okta	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.16 0.0%	$140.00	Buy
ORCL Oracle	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$283.29 -2.8%	$364.00
ORCL Oracle	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark L. Moerdler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$283.29 -2.8%	$363.00 ➝ $364.00	Outperform
ORGO Organogenesis	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.10 -12.4%	$7.00	Buy
OSIS OSI Systems	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mariana Perez Mora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$236.42 +2.1%	$250.00 ➝ $265.00	Buy
PANW Palo Alto Networks	Initiated by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.37 +0.1%	$245.00	Buy
PANW Palo Alto Networks	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Boyd Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.37 +0.1%	$245.00
PAYC Paycom Software	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jacob Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.73 +1.3%	$270.00	Buy
PAYX Paychex	Target Lowered by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.21 +1.2%	$145.00 ➝ $140.00	Underperform
POLB Poolbeg Pharma	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3.89 +1.0%
PSTG Pure Storage	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.46 -1.2%	$80.00 ➝ $100.00	Overweight
PSTG Pure Storage	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Amit Daryanani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.46 -1.2%	$85.00 ➝ $90.00	Outperform
PSTG Pure Storage	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.46 -1.2%	$85.00 ➝ $100.00	Buy
PSTG Pure Storage	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.46 -1.2%	$93.00 ➝ $105.00	Buy
PVLA Palvella Therapeutics	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geulah Livshits Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.59 +3.3%	$60.00 ➝ $73.00	Buy
QNCX Quince Therapeutics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.61 -1.2%	$4.00	Buy
RAPT Rapt Therapeutics	Upgraded by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.38 +7.9%	$16.00 ➝ $37.00	Market Perform ➝ Outperform
RL Ralph Lauren	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$312.04 +3.0%	$423.00 ➝ $430.00	Overweight
ROL Rollins	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tomohiko Sano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.45 +3.6%	$70.00	Overweight
RWT Redwood Trust	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Hagen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.76 -0.8%	$8.50	Buy
SEPL Seplat Energy	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 282.50 +0.5%	GBX 465 ➝ GBX 550	Buy
SMG Scotts Miracle-Gro	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.04 -1.0%	$71.00
SNX TD SYNNEX	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +3.1%	$173.00 ➝ $181.00	Overweight
SNX TD SYNNEX	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Paige Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +3.1%	$165.00 ➝ $180.00	Outperform
SNX TD SYNNEX	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +3.1%	$140.00 ➝ $164.00	Equal Weight
SNX TD SYNNEX	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ruplu Bhattacharya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.62 +3.1%	$170.00 ➝ $180.00	Buy
SPRY ARS Pharmaceuticals	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.80 +2.7%	$32.00
SPWR CSLM Acquisition	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gus Richard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.77 +8.6%	$3.00 ➝ $5.40	Outperform
SYRE Spyre Therapeutics	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hoang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.24 +4.0%	$43.00	Buy
TEM Tempus AI	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.48 +1.5%	$80.00 ➝ $95.00	Buy
THO Thor Industries	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.32 +0.5%	$112.00 ➝ $122.00	Neutral
THO Thor Industries	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tristan Thomas-Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.32 +0.5%	$105.00 ➝ $115.00	Outperform
TOY Spin Master	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$19.64 -6.9%	C$29.00 ➝ C$27.00	Outperform
TSLA Tesla	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edison Yu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$440.40 +4.0%	$345.00 ➝ $435.00	Buy
TSLA Tesla	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$440.40 +4.0%	$500.00 ➝ $600.00	Outperform
TSLA Tesla	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Narayan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$440.40 +4.0%		Buy
TTI Tetra Technologies	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Gibas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.91 +4.8%	$5.50 ➝ $7.00	Outperform
TWLO Twilio	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$102.33 +1.0%	$140.00	Buy
UAL United Airlines	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.91 -1.3%	$114.00 ➝ $131.00	Buy
UAMY United States Antimony	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.25 -1.0%	$4.50 ➝ $8.50	Buy
UEC Uranium Energy	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.67 +1.7%	$13.00 ➝ $17.00	Buy
UGP Ultrapar Participacoes	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bruno Amorim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.95 -0.6%	$4.00 ➝ $4.50	Buy
ULCC Frontier Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Atul Maheswari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.90 +2.7%	$3.50 ➝ $5.00	Neutral
UPS United Parcel Service	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.74 +1.4%	$83.00 ➝ $81.00	Underperform
USA Americas Silver	Target Set by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.85 +6.8%	C$6.00	Buy
USAS Americas Gold and Silver	Initiated by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.52 +7.6%		Buy
UTHR United Therapeutics	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Walter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$432.66 +1.7%	$569.00	Outperform
VCM Vecima Networks	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$10.37 -1.2%	C$15.00 ➝ C$17.00
VERX Vertex	Initiated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.97 +1.5%	$30.00	Overweight

VMI Valmont Industries	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tomohiko Sano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$385.54 +5.7%	$480.00	Overweight
WBD Warner Bros. Discovery	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Nispel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.51 -1.4%		Overweight ➝ Sector Weight
WIX Wix.com	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$177.42 +2.2%	$206.00 ➝ $210.00	Overweight
WRN Western Copper & Gold	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.98 +7.0%	$4.00 ➝ $4.25	Buy
WYFI WhiteFiber	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Golding Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.83 -3.2%	$28.00 ➝ $32.00	Outperform
XRAY DENTSPLY SIRONA	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.50 +1.1%		Hold
ZLNDY Zalando	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.38 -1.9%		Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:36 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings